Predictors of early high-level response to bimekizumab in patients with moderate-to-severe plaque psoriasis: a real-world cohort study.

Bimzelx (bimekizumab-bkzx) - UCB

http://www.ncbi.nlm.nih.gov/pubmed/42025118

Bengusu Yildiz; Burhan Engin; Fatma Zehra Diken; Gurbuz Yildirim; Server Serdaroglu; Yusuf Demir; Zekayi Kutlubay

Apr 24, 2026